| Similar Articles |
|---|
 |
Chemistry World
October 26, 2015
Emma Stoye |
Malaria vaccine pilot studies recommended by WHO The World Health Organization has said the RTS,S malaria vaccine should be tested further through a series of pilot studies before it can recommend its widespread use.   |
Chemistry World
October 9, 2013
Phillip Broadwith |
GSK to apply for malaria vaccine approval Preliminary results from the first ever Phase III clinical trial of a malaria vaccine show that it can reduce malaria infections in vaccinated children over 18 months. |
Pharmaceutical Executive
December 1, 2010
Walter Armstrong |
Vaccines: Progress in Preventing Bad Bugs Long on the sidelines of pharma R&D, vaccine development is moving to center stage as most of the big pharmas diversify, spreading their risk among the full gamut of revenue sources. |
Salon.com
December 15, 2000
Arthur Allen |
Warming to malaria With fears mounting that global climate change may cause the dreaded disease to spread, scientists turn their attention to vaccine research... |
Chemistry World
April 2008
Victoria Gill |
Malaria no More? A fresh round of research funding could put an end to the killer disease. |
HHMI Bulletin
Aug 2010
Robert Koenig |
Collaborating Across an Ocean to Stop Malaria Two scholars, one from Mali and one from the United States team up to produce a vaccine for malaria. |
Chemistry World
December 3, 2014
Maria Burke |
Ebola vaccine passes first safety hurdle The vaccine was developed collaboratively by scientists at the NIH's National Institute of Allergy and Infectious Diseases, and at Okairos, a biotechnology company acquired by GlaxoSmithKline. |
Chemistry World
June 17, 2015
James Urquhart |
Promising compound offers single dose knock-out for malaria Ian Gilbert and colleagues, working with the Medicines for Malaria Venture, have found a compound dubbed DDD107498 which kills Plasmodium falciparum -- the species responsible for most dangerous form of malaria. |
Pharmaceutical Executive
February 1, 2007
Joanna Breitstein |
Net Effect Ripley Ballou may finally win approval for a vaccine he started testing as an army physician more than 25 years ago - an advance that could mark the beginning of a whole new phase in the battle against one of the world's great killers: malaria. |
The Motley Fool
April 6, 2010
Brian Orelli |
Kill It! Double-Teaming Malaria Malaria vaccine might not make Glaxo and Crucell rich, but the life-saving and PR benefits would be welcome. |
Scientific American
September 2007
Jeffrey D. Sachs |
Ending Malaria Deaths in Africa One of the world's worst killers can be stopped soon if we make the investment. |
American Family Physician
May 15, 2001 |
Pneumococcal Conjugate Vaccine: What a Parent Needs to Know Why should my child get this vaccine?... What exactly is the pneumococcal vaccine?... Are there some children who should not get pneumococcal conjugate vaccine or who should wait until they are older?... |
BusinessWeek
April 26, 2004
Kerry Capell |
Vaccinating The World's Poor GlaxoSmithKline Biologicals is betting it can combat Third World scourges -- and still make money. |
American Family Physician
August 1, 2003 |
Preventing Malaria When You Travel What is malaria? Who gets it?... How is malaria transmitted?... Who is at risk for malaria?... How can I tell if I have malaria?... Can I do anything to keep from getting malaria?... What should I do if I think I have malaria?... etc. |
AskMen.com
Jacob Franek |
2008 Medical Science Developments Here are some 2008 medical science developments that might just yield the next big breakthrough. |
Chemistry World
September 16, 2015
Patrick Walter |
A shot in the arm It's heartening news that an Ebola vaccine has delivered outstanding results and that a malaria one shows early promise. |
AskMen.com
Dustin Driver |
Travel Diseases: Africa The allure of a safari through the Serengeti or a trek up Kilimanjaro may inspire you to strike out for the heart of Africa, but before you go there are a few things you should know: like, the huge continent is teeming with bug-borne, water-borne and human-borne diseases. |
American Family Physician
July 1, 2004
Lo Re & Gluckman |
Travel Immunizations The approach to vaccine recommendations should be based on a thorough assessment of the risks for travel-related diseases, the time available before trip departure, and current knowledge of the epidemiology of vaccine-preventable diseases. |
Geotimes
May 2005
Jeffrey Shaman |
Malaria Mapping and Prevention Today, scientists from various fields, including the geosciences, are contributing to the fight against malaria and other infectious diseases. |
AskMen.com
Dustin Driver |
Travel Diseases: Central & South America There are more than a few diseases that can turn your dream vacation to Central or South America into a nightmare -- so here are a few "ounces of prevention." |
Scientific American
October 2007
Jeffrey D. Sachs |
Ending Malaria Deaths in Africa One of the world s worst killers can be stopped soon if we make the investment. |
Pharmaceutical Executive
February 1, 2009
Joanna Breitstein |
Vaccines for All The world is suffering. But just over the horizon is a new access equation that could speed innovative vaccines to where they're needed most. |
American Family Physician
May 15, 2001
Richard Kent Zimmerman |
Pneumococcal Conjugate Vaccine for Young Children Pneumococcal conjugate vaccine, approved in 2000 for use in the United States, was designed to cover the seven serotypes that account for about 80 percent of invasive infections in children younger than six years... |
Health
May 2008
Jessica Snyder Sachs |
Seven Vaccines You Need Right Now Why those childhood shots (whooping cough, mumps, and more) may have worn off - and what to do. |
Chemistry World
February 5, 2014
Jenifer Mizen |
Protein-free and low sugar -- not a new diet, a new vaccine A Streptococcus pneumonia vaccine with fewer sugar units and no antigenic protein is not only easier to produce but could also induce a superior immune response to the vaccine currently in clinical use. |
American Family Physician
August 1, 2003
Lo Re & Gluckman |
Prevention of Malaria in Travelers As travel to tropical locations increases, U.S. physicians are being asked more frequently to provide recommendations for malaria prevention. An organized approach to reducing the risk of acquiring this disease is necessary. |
Chemistry World
January 29, 2015
Matthew Gunther |
Ebola vaccine shown to be safe in humans GlaxoSmithKline's experimental Ebola vaccine is capable of triggering an immune response in humans, according to a new study. |
Chemistry World
May 13, 2013
Harriet Brewerton |
Early malaria diagnosis Now, Nicholas Smith and colleagues at Osaka University have shown that Raman spectroscopy can detect changes in heme and hemozoin in plasma samples to identify malarial infection. |
American Family Physician
December 1, 2002
Sanford R. Kimmel |
Vaccine Adverse Events: Separating Myth from Reality Vaccines have turned many childhood diseases into distant memories in industrialized countries. However, questions have been raised about the safety of some vaccines because of rare but serious adverse effects that have been attributed to them. |
Wired
January 2003
Richard Martin |
Testing the First AIDS Vaccine Medical establishment, government, and Genentech be damned -- Don Francis has never stopped believing. Now he's about to finish testing the first human AIDS vaccine. |
AskMen.com
Dustin Driver |
Most Contagious Diseases Super-contagious diseases spread like wildfire. The best way to battle any of these nasty bugs is to avoid them altogether. Keep your eyes open for these most-unwanted diseases, and stay healthy. |
Chemistry World
January 18, 2013
Emma Eley |
New method to target malaria Malaria affects millions of people each year; however, no effective vaccines exist. Now, scientists from Spain have discovered a new strategy to target the disease. |
BusinessWeek
November 29, 2004
Kerry Capell |
"A Vaccine Every Woman Should Take" Two drug companies are closing in on shots against HPV, the leading cause of cervical cancer. Despite the obvious benefits, the vaccines may not be an easy sell: There are social and moral hurdles to overcome. |
Chemistry World
June 30, 2014
James Urquhart |
Smell of malaria attracts mosquitoes The word 'malaria' means 'bad air', but new research suggests the disease may actually make its victims smell good to mosquitoes. |
| AskMen.com |
Vaccine Helps Prevent HIV For the first time, an experimental vaccine has prevented infection with the AIDS virus, a watershed event in the deadly epidemic and a surprising result. |
Chemistry World
January 19, 2015
Maria Burke |
Roadmap to fast track Ebola vaccine development A global group of experts has developed a 'roadmap' to help the health community fast track an Ebola vaccine. |
American Family Physician
January 1, 2004 |
Hepatitis B Infection What is hepatitis B virus?... How can I tell if I have HBV infection?... What happens after HBV infection?... What health problems can chronic HBV infection cause?... How can I protect my liver if I have chronic HBV infection?... How can HBV infection be prevented?... etc. |
Chemistry World
September 10, 2007
Lewis Brindley |
Taking the Sting Out of Malaria Scientists have identified sugar chains lining the mosquito's gut that the malaria parasite latches onto to infect the insect. |
Pharmaceutical Executive
May 1, 2006
Pasternak et al. |
Vaccines: Market on the Rebound The vaccine business was safely inoculated against higher profits. But innovative therapies and looser government controls may spark an outbreak. Are pharmaceuticals ready for this opportunity? |
BusinessWeek
January 29, 2007
Kerry Capell |
GlaxoSmithKline: Getting AIDS Drugs To More Sick People GlaxoSmithKline sells 90% of its vaccines, in volume terms, at not-for-profit prices to customers in the developing world. |
HBS Working Knowledge
February 28, 2005
Cynthia Churchwell |
Funding R&D for Neglected Diseases Research on vaccines for diseases that primarily affect low-income countries remains minimal---the risks are too high for developers. The book Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases suggests a solution. |
American Family Physician
November 15, 2005
Sanford R. Kimmel |
Prevention of Meningococcal Disease Invasive disease caused by Neisseria meningitidis has an average annual incidence of one case per 100,000 in the United States. The disease can be rapidly fatal or result in severe neurologic and vascular sequelae despite antibiotic therapy. |
Chemistry World
August 5, 2015
Emma Stoye |
Vaccine raises hopes of an end to Ebola A Phase III trial for a candidate Ebola vaccine has shown extremely encouraging results in Guinea, demonstrating complete protection for all those who were vaccinated. |
Wired
September 2002
Amanda Griscom |
Take These Genes and Call Me in the Morning Gene vaccines may be relatively new, but they're the logical outgrowth of two familiar strands of medical science. |
Nurse Practitioner
December 2009
Gujral & Collantes |
Understanding Viral Hepatitis: A guide for primary care Recent advancements in the field of genomics and proteomics technology have given researchers and clinicians more insight on disease pathogenesis and helped create more tailored approaches to the treatment of these conditions. |
Chemistry World
July 23, 2013
Sonja Hampel |
Antigenic sugars identified for Chagas disease Scientists have synthesised the combinations of sugars from the surface of the Chagas disease parasite that trigger the human immune response to it. This could help establish better diagnostic tests for the disease, and even a vaccine. |
Chemistry World
October 23, 2014
Rebecca Trager |
US agency fast-tracks Ebola vaccine development The US Department of Health and Human Services is fast-tracking tests on an Ebola vaccine by providing $5.8 million under a one-year contract with the Maryland-based biotech company Profectus BioSciences |
BusinessWeek
July 25, 2005
Catherine Arnst |
O.K., Roll Up Your Sleeve New vaccines are arriving but the economics are still a challenge. |
Pharmaceutical Executive
May 1, 2006
Joanna Breitstein |
Cervical Cancer: Endagered Species Preventive care is more efficient than treating disease after the fact. Now this paradigm takes hold in cancer with new HPV vaccines. Now that the science is in order, Merck and GSK face several important challenges in conditioning the market. |
| AskMen.com |
The Upside Of Malaria New research is attempting the first live vaccine to fight malaria. |
